Embody vs Noom Med: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 15, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Noom Med scores higher on our rubric, 7.4/10 against 7.3/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Embody - from $69/mo →or find your match

Noom Med beats Embody overall, scoring 7.4/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Noom Med is $79 first month, then $199/mo. Choose Embody for people who want the oral tirzepatide gum, or who are comfortable selecting a 4-, 12-, 24- or 52-week plan for an advertised glp-1 + gip rate from $129. Choose Noom Med for users who want a low-dose glp-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing.

A side-by-side look at Embody and Noom Med to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Embody

#32 of 54

7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan. Its standout is oral tirzepatide gum for people who do not want injections.

Visit Embody

Higher Rated

Noom Med

#23 of 54

7.4/10

Noom restructured Noom Med in 2026 into a GLP-1 ladder plus a non-GLP-1 pill: Microdose GLP-1Rx at $79 then $199/mo, GLP-1Rx at $129 then $249/mo, GLP-1Rx Plus at $149 then $299/mo, and a metformin pill at $69 then $99/mo that is not a GLP-1. Verified 2026-07-27. Historic note: the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med

Feature	Embody	Noom Med
Why each one	One of the few GLP-1 providers offering oral tirzepatide as a chewable gum, a real choice for people who don't want injections.	The only GLP-1 platform built on a decade of behavioral psychology research, combining medication with Noom's proven coaching methodology for lasting habit change.
Our Score	7.3/10	7.4/10
Headline Price	from $69/mo	$79 first month, then $199/mo
Medication Type	Compounded	Both
Insurance Accepted	No	Yes
Best For	People who want the oral tirzepatide gum, or who are comfortable selecting a 4-, 12-, 24- or 52-week plan for an advertised GLP-1 + GIP rate from $129	Users who want a low-dose GLP-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing
Watch out for	Runs two sibling storefronts most shoppers will never connect to it: SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com) are the same legal entity, Modern Metabolic Medicine, Inc. SnagRx still advertises a separate $69/$119 promotion; Embody now advertises $79/$129 under its own plan menu. Neither site tells shoppers they share an operator. See our [SnagRx review](/reviews/snagrx)	Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]
Ranking	#32	#23
Get started	Visit Embody	Visit Noom Med

Pros & Cons Compared

Embody

Pros

+Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
+Advertised injection floors of $79 for semaglutide and $129 for GLP-1 + GIP, verified August 14, 2026. The FAQ says the selected rate holds within the chosen plan.
+Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
+100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
+Replies to every negative Trustpilot review, usually within 24 hours.

Cons

−Runs two sibling storefronts most shoppers will never connect to it: SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com) are the same legal entity, Modern Metabolic Medicine, Inc. SnagRx still advertises a separate $69/$119 promotion; Embody now advertises $79/$129 under its own plan menu. Neither site tells shoppers they share an operator. See our [SnagRx review](/reviews/snagrx)
−The $79/$129 figures are advertised floors tied to a selected 4-, 12-, 24- or 52-week plan, not a verified no-commitment month-to-month rate. Confirm the plan length and total before payment.
−Trustpilot rating is 3.8 / 5 across 5,305 reviews, verified August 14, 2026. Price and billing remain recurring complaint themes, although many reviews describe earlier pricing structures.
−Embody names four pharmacy partners: RedRock Pharmacy, Health Warehouse, Precision Compounding and Triad Rx. It does not state whether each prescription is filled through a 503A pharmacy or a 503B outsourcing facility. Triad Rx received a 2019 FDA warning letter for sterile-production violations; FDA closed it out in May 2023.
−No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
−Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
−If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.

Noom Med

Pros

+Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
+Microdose GLP-1Rx is $79 for the first 4 weeks then $199/mo billed quarterly, low-dose GLP-1 plus biomarker monitoring for side-effect-sensitive users [Verified 2026-07-27]
+Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
+Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

−Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]
−Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
−Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
−App coaching still requires real engagement, skip-prone users waste the behavioral value

Our Verdict

Noom Med edges out Embody with a score of 7.4/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Embody is from $69/mo; Noom Med is $79 first month, then $199/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Noom Med offers both brand-name and compounded medications, giving you more flexibility.